AlphaCrest Capital Management LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 255 filers reported holding TG THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
AlphaCrest Capital Management LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$328,000
-58.9%
77,224
-8.0%
0.02%
-64.4%
Q1 2022$798,000
+159.1%
83,924
+417.7%
0.04%
+309.1%
Q4 2021$308,000
-70.8%
16,210
-40.5%
0.01%
-75.6%
Q2 2021$1,056,000
+213.4%
27,227
+116.1%
0.04%
+21.6%
Q3 2020$337,000
+54.6%
12,600
+12.5%
0.04%
+2.8%
Q2 2020$218,000
-73.0%
11,200
-86.4%
0.04%
-63.3%
Q1 2020$808,000
+64.9%
82,100
+86.2%
0.10%
+145.0%
Q4 2019$490,00044,1000.04%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,434,783$60,326,0005.25%
RA Capital Management 9,880,323$109,672,0003.33%
BRIDGER MANAGEMENT, LLC 1,907,492$21,173,0001.53%
Eversept Partners, LP 776,323$8,617,1851.52%
Opaleye Management Inc. 579,651$6,434,0001.26%
Sofinnova Investments, Inc. 811,292$9,006,0000.65%
Ikarian Capital, LLC 316,200$3,510,0000.57%
ARMISTICE CAPITAL, LLC 800,000$8,880,0000.51%
683 Capital Management, LLC 398,271$4,421,0000.51%
Frontier Wealth Management LLC 196,750$2,184,0000.35%
View complete list of TG THERAPEUTICS INC shareholders